FDA 483 - Sparhawk Laboratories Inc - May 09, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Sparhawk Laboratories Inc. in Lenexa, KS, revealed significant deficiencies in aseptic processing procedures, personnel practices, and environmental monitoring for sterile drug products. The inspection also identified issues with laboratory controls, including inaccurate documentation of microbial monitoring and inadequate qualification procedures for personnel. These findings indicate a serious lack of control over critical manufacturing and testing processes, potentially impacting product sterility and quality.
ID · 18dcdbda-bfed-4f13-ba34-a26a0c5c8252